Questcor to Report Fourth Quarter and Full Year 2013 Financial Results on
February 25, 2014
ANAHEIM, Calif., Feb. 12, 2014
ANAHEIM, Calif., Feb. 12, 2014 /PRNewswire/ --Questcor Pharmaceuticals, Inc.
(Nasdaq: QCOR) today announced that it will release fourth quarter and full
year 2013 financial results on Tuesday, February 25, 2014 after the close of
the U.S. financial markets. The Company will host a conference call and slide
presentation via webcast on Tuesday, February 25, 2014 at 4:30 p.m. Eastern /
1:30 p.m. Pacific to discuss results and corporate developments.
The call can be accessed in the following ways:
oBy webcast: At Questcor's investor relations website,
oBy telephone: For both "listen-only" participants and those participants
who wish to take part in the question-and-answer portion of the call, the
dial-in number in the U.S. is (877) 354-0215. For participants outside the
U.S., the dial-in number is (253) 237-1173.
oBy audio replay: A replay of the conference call will be available for
seven business days following conclusion of the live call. The telephone
dial-in number for U.S. participants is (855) 859-2056. For participants
outside the U.S., the replay dial-in number is (404) 537-3406. The replay
access code for all callers is 55826448.
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune and
inflammatory disorders. Questcor also provides specialty contract
manufacturing services to the global pharmaceutical industry through its
wholly-owned subsidiary BioVectra Inc. For more information about Questcor,
please visit www.questcor.com.
SOURCE Questcor Pharmaceuticals, Inc.
Contact: Investors, EVC Group, Gregory Gin/Patty Eisenhaur, 714-497-4899,
Media, EVC Group, Janine McCargo, 646-688-0425
Press spacebar to pause and continue. Press esc to stop.